1,451
Views
5
CrossRef citations to date
0
Altmetric
Coronavirus – Research Article

Clinical characteristics in immune thrombocytopenia patients after COVID-19 vaccination

, , , , &
Article: 2119043 | Received 07 Jun 2022, Accepted 26 Aug 2022, Published online: 07 Sep 2022

References

  • Zeng QL, Lv YJ, Liu XJ, Jiang ZY, Huang S, Li WZ, Yu ZJ. Clinical characteristics of Omicron SARS-CoV-2 variant infection after non-mRNA-based vaccination in China. Front Microbiol. 2022;13(901826). doi:10.3389/fmicb.2022.901826.
  • Fiolet T, Kherabi Y, MacDonald CJ, Ghosn J, Peiffer-Smadja N. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. Clin Microbiol Infect. 2022;28(2):1–7. doi:10.1016/j.cmi.2021.10.005.
  • Mingot-Castellano ME, Butta N, Canaro M, Solano MDGD, Sanchez-Gonzalez B, Jimenez-Barcenas R, Pascual-Izquierdo C, Caballero-Navarro G, Urena LE, Gonzalez-Lopez TJ, et al. COVID-19 vaccines and autoimmune hematologic disorders. Vaccines. 2022;10(6):961. doi:10.3390/vaccines10060961.
  • Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Perez Marc G, Moreira ED, Zerbini C, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603–2615. doi:10.1056/NEJMoa2034577.
  • Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403–416. doi:10.1056/NEJMoa2035389.
  • Park JY, Kim JH, Lee IJ, Kim HI, Park S, Hwang YI, Jang SH, Jung KS. COVID-19 vaccine-related interstitial lung disease: a case study. Thorax. 2021;77(1):102–104. doi:10.1136/thoraxjnl-2021-217609.
  • Schultz NH, Sorvoll IH, Michelsen AE, Munthe LA, Lund-Johansen F, Ahlen MT, Wiedmann M, Aamodt AH, Skattor TH, Tjonnfjord GE, et al. Thrombosis and thrombocytopenia after ChAdox1 nCov-19 vaccination. N Engl J Med. 2021;384(22):2124–2130. doi:10.1056/NEJMoa2104882.
  • Singh S, Sharma R, Singh J, Jain K, Paul D. Thrombocytopenia in COVID-19: focused summary of current understanding of mechanisms and clinical implications. J Pediatr Hematol Oncol. 2021;43(7):243–248. doi:10.1097/MPH.0000000000002264.
  • Liu XG, Bai XC, Chen FP, Cheng YF, Dai KS, Fang MY, Feng JM, Gong YP, Guo T, Guo XH, et al. Chinese guidelines for treatment of adult primary immune thrombocytopenia. Int J Hematol. 2018;107(6):615–623. doi:10.1007/s12185-018-2445-z.
  • Hemostasis Group. Association CSoHCM. Chinese guideline on the diagnosis and management of adult primary immune thrombocytopenia (version 2020). Zhonghua Xue Ye Xue Za Zhi. 2020;41(8): 617–623. in Chinese. doi:10.3760/cma.j.issn.0253-2727.2020.08.001.
  • Feng YM, Xiao YS, Yan HJ, Wang P, Zhu W, C K, Zou Z, Wang K, Chen T, Quan Y. Sirolimus as rescue therapy for refractory/Relapsed immune thrombocytopenia: results of a single-center, prospective, single-arm study. Front Med. 2020;7:110. doi:10.3389/fmed.2020.00110.
  • Zhang C, Liu HF, Chen XH, Gao L, Gao L, Liu Y, Kong PY, Sun AH, Zhang X. Is splenectomy necessary for immune thrombocytopenic purpura? The role of rituximab in patients with corticosteroid resistance in a single-center experience. Clin Ther. 2014;36(3):385–388. doi:10.1016/j.clinthera.2014.01.017.
  • Feng Y, Chen X, Cassady K, Zou Z, Yang S, Wang Z, Zhang X. The role of mTOR inhibitors in hematologic disease: from bench to bedside. Front Oncol. 2020;10:611690).
  • Dijk W, Schutgens REG. Relapse of immune thrombocytopenia after COVID-19 vaccination. Eur J Haematol. 2022;108(1):84–85. doi:10.1111/ejh.13713.
  • Kuter DJ. Exacerbation of immune thrombocytopenia following COVID-19 vaccination. Br J Haematol. 2021;195(3):365–370. doi:10.1111/bjh.17645.
  • Shah SRA, Dolkar S, Mathew J, Vishnu P. COVID-19 vaccination associated severe immune thrombocytopenia. Exp Hematol Oncol. 2021;10(1):42. doi:10.1186/s40164-021-00235-0.
  • Kragholm K, Sessa M, Mulvad T, Andersen MP, Collatz-Christensen H, Blomberg SN, Lippert F, Mikkelsen S, Leutscher P, Melgaard D, et al. Thrombocytopenia after COVID-19 vaccination. J Autoimmun. 2021;123(102712):102712. doi:10.1016/j.jaut.2021.102712.
  • Welsh KJ, Baumblatt J, Chege W, Goud R, Nair N. Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the vaccine adverse event reporting system (VAERS). Vaccine. 2021;39(25):3329–3332. doi:10.1016/j.vaccine.2021.04.054.
  • Shonai T, Kimura F, Watanabe J. Severe immune thrombocytopenia after COVID-19 vaccination: two case reports and a literature review. Intern Med. 2022;61(10):1581–1585. doi:10.2169/internalmedicine.9177-21.
  • Sivaramakrishnan P, Mishra M. Vaccination-Associated immune thrombocytopenia possibly due to ChAdox1 nCov-19 (Covishield) coronavirus vaccine. BMJ Case Rep. 2022;15(3):e249237. doi:10.1136/bcr-2022-249237.